Boston Scientific | BSX - Loan Capital


Boston Scientific reported $10.99B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
AtriCure USD 61.86M 0 Dec/2025
Avanos Medical USD 90.3M 3.1M Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Boston Scientific USD 10.99B 12M Sep/2025
CONMED USD 853.01M 28.1M Sep/2025
Cooper Companies USD 2.46B 26.1M Sep/2025
Danaher USD 18.42B 1.58B Dec/2025
Dexcom USD 1.24B 53.6M Dec/2025
Edwards Lifesciences USD 598.2M 200K Sep/2025
Globus Medical USD 427K 254K Sep/2025
Hologic USD 2.5B 2.1M Dec/2025
Illumina USD 1.49B 496M Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 39.44B 30M Dec/2025
Masimo USD 559.1M 39.6M Sep/2025
Medtronic USD 27.62B 1.45B Sep/2025
Merit Medical Systems USD 734.04M 1.12M Dec/2025
Stryker USD 14.86B 14M Dec/2025
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
Zimmer Biomet Holdings USD 6.93B 580.6M Dec/2025